Maximus, Inc. (NYSE:MMS - Get Free Report) declared a quarterly dividend on Monday, January 6th,RTT News reports. Shareholders of record on Saturday, February 15th will be given a dividend of 0.30 per share by the health services provider on Friday, February 28th. This represents a $1.20 annualized dividend and a yield of 1.56%.
Maximus has increased its dividend payment by an average of 2.3% per year over the last three years. Maximus has a dividend payout ratio of 19.2% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Maximus to earn $5.70 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 21.1%.
Maximus Stock Performance
NYSE MMS traded down $0.50 on Monday, hitting $77.00. 928,972 shares of the company's stock were exchanged, compared to its average volume of 698,824. The firm has a market cap of $4.64 billion, a price-to-earnings ratio of 15.40 and a beta of 0.73. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49. The firm's 50-day moving average price is $77.56 and its two-hundred day moving average price is $85.18. Maximus has a fifty-two week low of $69.72 and a fifty-two week high of $93.97.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on MMS shares. StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a report on Friday, December 27th. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a report on Thursday.
View Our Latest Report on Maximus
Insider Activity at Maximus
In related news, CEO Bruce Caswell bought 3,500 shares of Maximus stock in a transaction that occurred on Tuesday, December 17th. The shares were purchased at an average price of $70.64 per share, with a total value of $247,240.00. Following the purchase, the chief executive officer now owns 275,929 shares in the company, valued at $19,491,624.56. This represents a 1.28 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Raymond B. Ruddy bought 3,490 shares of Maximus stock in a transaction that occurred on Thursday, December 12th. The stock was bought at an average cost of $71.46 per share, for a total transaction of $249,395.40. Following the purchase, the director now owns 112,520 shares in the company, valued at $8,040,679.20. This represents a 3.20 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have purchased 7,063 shares of company stock valued at $502,017. 1.40% of the stock is owned by corporate insiders.
About Maximus
(
Get Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.